ʻO MingCeler ka mea ʻepekema nui

Kauka Guangming Wu, PhD

Ua hana ʻo Kauka Guangming Wu, ke kaukaʻi o Guangzhou Bio-land Laboratory, ma ke ʻano he hoa noiʻi a i ʻole postdoctoral hoa ma New England Medical Animal Center, Brown University, University of Missouri-Columbia, Temple University School of Medicine, a me nā ʻoihana noiʻi kaulana ʻē aʻe. .Ma 2004, ua komo ʻo ia i ka Max Planck Institute for Molecular Biology (MPI) ma Kelemānia, kahi āna i hana pū ai me Prof. Hans R. Schöler (Member o ka German National Academy of Science) ma ka hoʻomohala ʻana i nā embryos ʻiole a me nā ʻōnaehana stem cell.

Ke hana nei ʻo Dr. Wu i nā molecular mechanisms o ke kanaka, porcine, bovine, a me ka ʻiole oocyte a me ka ulu ʻana o ka embryonic mua, a me ka hoʻokumu ʻana o ka totipotensi a me ka pluripotency no nā makahiki he 30, a ua ʻike maikaʻi ʻia i nā ʻano embryonic in vitro moʻomeheu a me ka micro. ʻenehana hoʻopunipuni.ʻO ia ka mea mua a i kēia manawa ʻo ia wale nō ka ʻepekema e hoʻonui i ka helu hānau o nā ʻiole i loaʻa mai ka ʻenehana uku tetraploid mai 1-5% a 30-60% ma o ka optimization, e hoʻokō i ka industrialization o ka ʻenehana.Ua kākau pū ʻo ia i nā pepa SCI 79 me kahi mea hopena i hui pū ʻia ma luna o 670 a ma luna o 7150 mau huaʻōlelo a ua paʻi ʻia ma nā nūpepa honua kiʻekiʻe e like me Nature, Cell stem cell, etc.

No kāna kōkua koʻikoʻi i ka hoʻopololei ʻana, ua hōʻike mau ʻia ka inoa o Kauka Wu ma ka Hale Hōʻikeʻike ʻo Deutsches o Munich, ʻo ia ka hale hōʻikeʻike ʻepekema a me ka ʻenehana nui loa o ka honua.

I ʻAukake 2019, ua hoʻokomo hou ʻia ʻo Dr. Wu i Kina ma ke ʻano he mea noiʻi piha, ua hana maikaʻi ʻo ia a me kāna hui noiʻi i kahi hoʻohālike kiʻi kanaka ACE2 kanaka i loko o 35 mau lā, e waiho ana i kahi "kumu" hoʻokolohua no ka noiʻi ʻana o COVID-19 pathogenesis. ka nānā ʻana i ka lāʻau lapaʻau, a me ka hoʻomohala ʻana i nā kano.Ma muli o kāna mau hoʻokō maikaʻi loa i ka ʻepekema a me ka ʻenehana, ua loaʻa iā Dr. Wu ka "Advanced Individual in Fighting against COVID-19 in Guangdong Province" i 2020.

ʻO ka hoʻomohala kūleʻa a me ka hoʻohana ʻana i ka ʻenehana hou loa ʻo Tetraploid Complementation ʻenehana (TurboMice™ ʻenehana) i ka hoʻohālike ʻiole i ka wā o ka hakakā ʻana me COVID-19, e paipai iā Kauka Wu e hoʻoikaika i ka waiwai nui i ka hoʻomohala ʻana i nā biopharmaceuticals.No laila, ua hoʻokumu ʻo ia ʻo Guangzhou MingCeler Biotech Co., Ltd ma ke ʻano he ʻepekema poʻokela, e hana ana i ka hoʻololi ʻana o ka ʻenehana TurboMice ™ mai ke keʻena ʻenehana i nā noi ʻoihana e hoʻolako i nā huahana kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻekiʻe kiʻiʻiole iole huahana a me nā lawelawe no ka honua kulanui, noiʻi institutes, halemai, a me nā hui lāʻau lapaʻau i komo i ka noiʻi olakino ola.